Background: International comparisons of disease prevalence have been useful in understanding what proportion of disease might be preventable and in informing potential policy interventions in different cultural and economic contexts. Using newly available, harmonized data from 20 countries, we compare disability and morbidity of older adults between the ages of 55 and 74. Methods: The Gateway to Global Aging Data, a data and information portal, provides access to easy-to-use individual-level longitudinal data from 10 surveys covering over 30 countries. Exploiting harmonized measures available from the Gateway, we descriptively examine how disability and morbidity differ across countries. Results: Significant cross-country differences are observed for several health indicators. Comparing countries with the highest and lowest prevalence rates, we observe that hypertension rates vary twofold and stroke rates vary threefold, while disability and arthritis rates vary more than fivefold. Among women, higher gross domestic product and life expectancy are related to lower diabetes, heart disease, and better functioning. Among men, national indicators of economic conditions are not significantly associated with reported disease prevalence. Conclusions: We document substantial heterogeneity in disability and morbidity across countries, separately for men and women and after controlling for population age composition and education. Rich data from various surveys across the world offers remarkable opportunities for cross-country analyses, calling for further investigation of what drives observed differences. The Gateway to Global Aging Data provides easy-to-use harmonized data files and tools to facilitate this type of research.
International comparisons and the subsequent ranking of countries is a popular endeavor in public health research. These comparisons can be useful in understanding the success and failure of public health policies and be used to inform potential policy interventions. Well-harmonized data with common standards of definitions and thorough documentation are prerequisites for such comparisons. In their absence, cross-country analyses may give rise to inconsistent results and to diverging conclusions (1) .
The Gateway to Global Aging Data (g2aging.org) is a data and information platform developed to facilitate cross-country analyses using the Health and Retirement Study (HRS)-family of surveys. The Gateway has compiled and indexed metadata (ie, the content and flow of the questionnaires, information about samples, etc.) from all available waves of the HRS and its sister surveys, enabling users to quickly attain concordant information across surveys for over 30 countries, and across waves of individual surveys. The Gateway also provides Harmonized data files that can be readily used for analyses across countries and over time. The complexity of survey design and the challenges of longitudinal linkages result in significant costs to construct suitable datasets for international investigations. The harmonized data files have been built to significantly reduce such costs and to minimize errors, therefore increasing replicability of scientific findings.
Using the harmonized measures available from the Gateway, we describe health outcomes, particularly disability and morbidity, across countries, focusing on older adults between the ages of 55 and 74. We also relate individual-level health outcomes to a country's macro-level characteristics, such as the levels of economic development and inequality.
Methods

Data Sources
For our analysis, we use the Harmonized data files built from individual-level data from seven HRS-family surveys. The HRS is a biennial panel study that surveys a representative sample of Americans over the age of 50 and their spouses. It has been conducted since 1992 and includes a refresher cohort of persons 50-56 every 6 (2) (3) (4) (5) (6) (7) (8) .
In addition to the individual-level data, we use countries' macroeconomic characteristics, such as the level of economic development and economic inequality, as well as life expectancy. Specifically, we include Gross Domestic Product (GDP) per capita, as provided by the World Bank, the Gini coefficient, as provided by the OECD and World Bank, and life expectancy at age 50 from the World Health Organization (9) (10) (11) (12) . The Gini coefficient is a measure of income inequality which captures the degree to which an economy deviates from a perfectly equal distribution of income on a scale from zero to one, where zero represents perfect equality (everyone has the same income) and a one represents perfect inequality (one person has all the income, all others have none).
Harmonized Measures
We use several measures drawn from the study specific harmonized datasets which assess demographic, socioeconomic, and health status. Attainment of tertiary education is harmonized across surveys based on the UNESCO 1997 International Standard Classification of Education (13) . Disability is indicated by having difficulty with at least one of five activities of daily living (ADL) tasks: bathing, dressing, eating, getting in and out of bed, and using the toilet. Five diseases, reported by respondents as having been diagnosed by a doctor, are included as health indicators, namely diabetes, heart conditions, stroke, hypertension, and arthritis. Further details of variable definitions are available from the codebooks of the harmonized data files. Tables 1 and 2 show descriptive statistics on selected health indicators for men and women, respectively. In order to report nationallevel or country-specific population estimates, we use the sample weights provided by each study and account for complex survey design by using stratum and cluster variables.
Statistical Analysis
At the country level, we examine the association between national macro characteristics and the prevalence of diseases using Pearson correlation coefficients (Table 3) . At the individual level, we estimate a probit model for each health indicator with a set of country dummy variables, controlling for age, gender, and education, to gauge cross-country differences. We omit the United States dummy; hence, we estimate country-specific differences relative to the United States. We discuss the results of the probit analysis in the text and present the full set of estimated coefficients in Supplementary Appendix Table 2 . All analyses were performed using Stata 14.
In Figure 1 , we document patterns of ADL disability, defined as difficulty performing at least one of five specific ADL tasks, by sex and age across countries. For this purpose, we group SHARE countries into four geographic regions of Europe.
Results
We observe significant cross-country variations in disability and morbidity, as shown in Tables 1 and 2 . The prevalence of ADL disability among individuals aged 55-74 ranges from 3%-4% in Korea, Japan, and Switzerland to 13%-14% in China, Estonia, and England for men, and from 2%-4% in Korea and Switzerland to over 15% in China, Mexico, and England for women. Cross-country variation in morbidity is also substantial. The prevalence rate for diabetes varies threefold for men and fivefold for women, the prevalence rate for heart disease varies fivefold for both men and women, the prevalence rate for stroke varies fourfold for men and threefold for women, and the prevalence rate for hypertension varies about twofold for both men and women. The prevalence rate for arthritis exhibits more pronounced variation across countries. For men, it increases almost 14 times from the lowest value of 3.4% in Japan to the highest value of 46.8% in the United States, while for women, it varies sixfold.
The countries considered in this study, which represent both newly developing economies, such as China and Mexico, and longdeveloped ones, like England, Sweden, and the United States, have a range of GDP per capita from just over $11,000 in China, to more than $91,000 in Luxembourg. Income inequality is quite variable across these countries; it is relatively large in Mexico, China, and the United States, and more modest in Slovenia, France, and Denmark. Life expectancy is highest in Switzerland for men and in Japan for women. The educational level of the older population computed from the harmonized data also shows tremendous differences across countries, with China and Denmark having the lowest and highest number of older adults with a tertiary education, respectively.
Among men, country-specific disease prevalence is not associated with either the level of GDP or the level of income inequality as represented by the Gini coefficient. Nor is educational attainment or life expectancy related to the prevalence of heart disease, diabetes, stroke, hypertension, or arthritis (lack of association is indicated by no coefficient in Table 3 being statistically significant). ADL disability for men is less prevalent in countries with higher life expectancy. For women, hypertension is less prevalent in countries with higher GDP, diabetes is less prevalent in countries with more inequality, heart disease is less prevalent in countries with higher life expectancy, and stroke is more prevalent where women have higher education. Among women, ADL disability is more likely in nations with more income inequality and lower life expectancy.
We also examine the prevalence of ADL disability in each country/region separately for men and women (Figure 1) . The steepness of age gradients in disability prevalence varies greatly across countries and by gender. For instance, relatively stable levels of disability are observed among women in the United States, Northern Europe, and Korea, while sharp increases with age are detected for men in England, China, and Mexico, and in Israel for both men and women. In most countries/regions, gender-specific age gradients are similar, with the exception of Northern Europe and Mexico, where men exhibit much steeper increases in disability than women. The prevalence of disability is the lowest among Korean women; even for those aged 70-75 years, the rate of disability is substantially lower than that of women in their 50s in other countries.
Discussion
Our study is observational in design. With the exception of Table 3 , our units of analysis are individuals living in a given country at a particular point in time. We use study-specific sample weights to obtain national-level statistics. These weights were constructed by the originating studies to make the weighted sample of each study representative of all individuals in the country's population within the age-eligible range used for sampling. To the extent that the age-eligible range varies (although slightly) across studies, observed differences across countries may also reflect differences in the composition of the reference populations.
In Table 3 , we document associations between national macroeconomic characteristics and the prevalence of diseases. In this case, our units of analysis are countries and, to avoid the ecological inference fallacy, one should refrain from interpreting the observed aggregate associations as individual-level associations. (11) and is a measure of inequality, ranging from 0 (complete equality) to 1 (complete inequality). For instance, a positive correlation at the country level between tertiary education and prevalence of stroke for women should not be considered informative of the relative likelihood of highly educated women having a stroke, but may indicate that people living in more educated countries are more likely to report strokes because they have more medical care. It could also reflect that people in these countries are more likely to survive strokes and be alive to report them. Gini coefficient in 2012 is taken from OECD (10) and World Bank (11) and is a measure of inequality, ranging from 0 (complete equality) to 1 (complete inequality). (11) and is a measure of inequality, ranging from 0 (complete equality) to 1 (complete inequality). While subject to these caveats and their descriptive nature, the results of this study add to our knowledge about the variability in the prevalence of disability and morbidity across countries. Generally, the prevalence of disability and morbidity exhibits substantial cross-country heterogeneity. Even the health outcome with the lowest observed variability, hypertension, has a prevalence rate varying twofold across the selected countries. For arthritis, the prevalence rate in some countries is over 10 times larger than others. Such astonishing differences suggest that there is room to improve population health in many countries. An important next step is to learn from the better performing countries and to design effective policies for improving health.
Our results add geographic breadth to the existing literature documenting cross-country variation in health (14, 15) . They also contribute to our understanding of the persistence of sex differences in health outcomes around the world (16) and of the changing links between economic progress and increases in health and life expectancy (17) . The Gateway to Global Aging Data supports in-depth analyses of international differences in health and supports further investigation of factors that may contribute to such cross-country differences, such as health behaviors, economic circumstances, and other sociodemographic characteristics.
Conclusions
Cross-country disparities in mortality and life expectancy are well-documented but much less is known about other dimensions of health. Using harmonized data from the Gateway to Global Aging Data that provides comparable measures of health and other key characteristics of individuals and households, we find that both disability and morbidity vary greatly across countries, and that the level of economic development is not the main driver of these differences. Substantial variation in population health calls for attention from both scientists and policy makers. As some countries do much better than others as far as disability and morbidity prevalence rates are concerned, it is important to identify what contributes to such cross-country differences so as to reduce existing gaps and to improve population health world-wide. Internationally harmonized data provide a unique opportunity to deepen our understanding of aging, particularly of what might contribute to observed heterogeneity in aging processes across countries around the world, and to represent a promising avenue for future research.
